| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | — |
| Cost of Revenue | $2.5M | +344.3% |
| Gross Profit | -$1.3M | -135.5% |
| R&D Expense | $24.4M | +44.9% |
| SG&A Expense | $37.3M | +7.6% |
| Operating Income | -$63.0M | -21.0% |
| Interest Expense | $2.9M | +9606.7% |
| Pre-tax Income | -$64.3M | -8.2% |
| Net Income | -$60.2M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.4M | -61.0% |
| Short-term Investments | $23.1M | +38.1% |
| Accounts Receivable | $319K | -24.0% |
| Inventory | $2.1M | +88.4% |
| Current Assets | $43.9M | -26.0% |
| Total Assets | $57.0M | -17.1% |
| Current Liabilities | $11.6M | -41.5% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.0M | -69.7% |
| Capital Expenditures | $5.7M | +48.2% |
| Investing Cash Flow | -$12.2M | +40.6% |
| Financing Cash Flow | $43.2M | +1501.1% |
| Free Cash Flow | -$61.8M | -67.4% |
| -7.9% |
| EPS (Basic) | -$1.82 | +2.2% |
| EPS (Diluted) | -$1.82 | +2.2% |
| Long-term Debt |
| $17.5M |
| +8650.0% |
| Total Liabilities | $29.8M | +11.4% |
| Stockholders' Equity | $25.0M | -33.9% |